India's pharmaceutical industry could benefit from a free trade agreement with the Association of South East Asia Nations, with additional deals under discussion. GK Pillai, the Commerce Secretary told reporters that "we will try to conclude free trade agreements with Japan and [South] Korea this year." A target of $20.0 billion in trade between Japan and India is the goal in 2010, up from $8.5 billion in 2006. India's drugmakers only have $200.0 million sales per year to Japan, out of a pharmaceutical market of $64.4 billion (Marketletter September 22).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze